Estland - Estlands - Ravimiamet

teva pharma b.v. - kandesartaan - tablett - 16mg 100tk; 16mg 98tk; 16mg 7tk; 16mg 20tk; 16mg 60tk; 16mg 50tk; 16mg 56tk; 16mg 90tk; 16mg 14tk

Estland - Estlands - Ravimiamet

fatro s.p.a. - marbofloksatsiin - süstelahus - 40mg 1ml 250ml 1tk; 40mg 1ml 100ml 1tk; 40mg 1ml 50ml 1tk

Estland - Estlands - Ravimiamet

zentiva k.s. - atorvastatiin+esetimiib - tablett - 10mg+10mg 100tk; 10mg+10mg 30tk; 10mg+10mg 90tk

Estland - Estlands - Ravimiamet

zentiva k.s. - atorvastatiin+esetimiib - tablett - 80mg+10mg 100tk; 80mg+10mg 30tk; 80mg+10mg 90tk

Estland - Estlands - Ravimiamet

zentiva k.s. - atorvastatiin+esetimiib - tablett - 40mg+10mg 100tk; 40mg+10mg 10tk; 40mg+10mg 90tk; 40mg+10mg 30tk

Estland - Estlands - Ravimiamet

grindeks as - asitromütsiin - õhukese polümeerikattega tablett - 500mg 3tk

Estland - Estlands - Ravimiamet

vetoquinol biowet sp. z o.o. - enrofloksatsiin - süstelahus - 50mg 1ml 100ml 1tk

Estland - Estlands - Ravimiamet

vetpharma animal health s.l. - linkomütsiin - pulber joogivees manustamiseks - 400mg 1g 150g 1tk; 400mg 1g 1000g 1tk

Europese Unie - Estlands - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - muud närvisüsteemi ravimid - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Estland - Estlands - Ravimiamet

huvepharma eood - tiamuliin - süstelahus - 162mg 1ml 100ml 1tk